ClawHub

Amgen

v1.0.0

全球第三大生物技术公司，专注肿瘤学、骨科学及炎症，2024年营收约290亿美元，拥有领先重组蛋白技术和产品组合。

⭐ 0· 120·0 current·0 all-time
by@hanxueyuan

Install

OpenClaw Prompt Flow

Install with OpenClaw

Best for remote or guided setup. Copy the exact prompt, then paste it into OpenClaw for hanxueyuan/amgen.

Previewing Install & Setup.
Prompt PreviewInstall & Setup
Install the skill "Amgen" (hanxueyuan/amgen) from ClawHub.
Skill page: https://clawhub.ai/hanxueyuan/amgen
Keep the work scoped to this skill only.
After install, inspect the skill metadata and help me finish setup.
Use only the metadata you can verify from ClawHub; do not invent missing requirements.
Ask before making any broader environment changes.

Command Line

CLI Commands

Use the direct CLI path if you want to install manually and keep every step visible.

OpenClaw CLI

Bare skill slug

openclaw skills install amgen

ClawHub CLI

Package manager switcher

npx clawhub@latest install amgen
Security Scan
VirusTotalVirusTotal
Benign
View report →
OpenClawOpenClaw
Benign
high confidence
✓
Purpose & Capability
Name/description (Amgen company profile) match the SKILL.md content. The skill does not declare or request unrelated binaries, credentials, or config paths.
✓
Instruction Scope
SKILL.md contains static company information and 'read_when' triggers for relevant queries (company info, competition, business model, investment analysis). It does not instruct the agent to read local files, access other environment variables, or transmit data to external endpoints.
✓
Install Mechanism
No install spec and no code files are present (instruction-only), so nothing is written to disk or downloaded during install.
✓
Credentials
The skill requires no environment variables, credentials, or config paths. No disproportionate secret access is requested.
✓
Persistence & Privilege
always is false and there is no indication the skill modifies agent/system settings or requests long-term presence. Autonomous invocation is allowed (platform default) but presents minimal risk given the skill's read-only, static nature.
Assessment
This skill is essentially a static Amgen company profile and is internally coherent. Before relying on it for decisions: verify facts (dates, revenues, drug approvals) against primary sources (Amgen filings, press releases, regulators), be aware the SKILL.md may be outdated or contain inaccuracies, and do not expect it to perform network or system actions—there are no credentials or install steps. If you need live data (stock prices, filings), prefer a skill that declares the specific API and credentials it uses.

Like a lobster shell, security has layers — review code before you run it.

latestvk972sv2vdsp0j9qf7ftytz7fcd855r6r
120downloads
0stars
1versions
Updated 1w ago
v1.0.0
MIT-0
@hanxueyuan
latest
Download

安进 · Amgen

"生物技术行业的奠基者，重组蛋白药物的开拓者"

Amgen 是全球生物技术行业的先驱和领导者之一，成立于 1980 年。公司利用重组 DNA 技术开发了多种革命性药物，在肿瘤学骨科学炎症和心血管疾病领域拥有强大的商业化产品组合。

历史时间线

时期关键事件
1980风险投资家 William Bowes 和科学家团队在加州创立
1983在纳斯达克上市，生物技术行业早期上市公司
1989Epogen 促红细胞生成素获批，首个商业化重组蛋白药物
2000以 190 亿美元收购 Immunex，获得 Enbrel
2011Xgeva 和 Prolia 骨科学药物获批上市
2019以 278 亿美元收购 Otezla 的母公司
2021Lumakras 肺癌靶向药物获批，突破 KRAS 不可成药靶点
2024肥胖症药物 MariTide 进入三期临床，开启新增长曲线

业务结构分析

肿瘤学

肺癌血液肿瘤和乳腺癌靶向治疗药物组合

骨科学

Prolia 和 Xgeva 骨质疏松和骨转移治疗，市场领先

炎症

Enbrel 和 Otezla 自身免疫疾病治疗药物

心血管和代谢

Repatha 降胆固醇药物和 MariTide 肥胖症在研管线

核心护城河

  生物技术飞轮
    |
    重组DNA技术平台 --> 持续创新
    |                                |
    大规模临床开发 --> 重磅药物
    |                                |
    全球商业化网络 --> 收入增长
    |                                |
    并购补充管线 --> 多元化
  1. 重组蛋白药物领域的先驱，拥有超过 40 年的技术积累
  2. Enbrel 是全球销量最高的自身免疫药物之一，累计销售超过 1000 亿美元
  3. Lumakras 首次突破了 KRAS 突变这个数十年不可成药的靶点
  4. 在肥胖症领域的 MariTide 可能成为下一个重磅增长驱动

关键数据

指标数值
年营收约 290 亿美元（2024）
Enbrel年销约 50 亿美元
Prolia年销约 35 亿美元
员工数约 25,000 人
研发投入占比约 25%
全球市场覆盖超过 100 个国家

值得了解

  • Amgen 这个名字来自 AMGen 即 Applied Molecular Genetics 的缩写

  • 公司总部所在的千橡市 Thousand Oaks 现在是全球生物技术产业的中心之一

  • Epogen 是第一个利用重组 DNA 技术大规模生产的蛋白质药物

  • Lumakras 的发现过程被 Science 杂志评为 2021 年十大科学突破之一

Comments

Loading comments...